Last quarter (Q ), NuGene International's total revenue was $586.60K, an increase of 12.16% from the same quarter last year. In Q, NuGene International's net income was $-1.18M. See NuGene International’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 16	Dec 15	Dec 14
Total Revenue	$ 2.00M	$ 1.97M	$ 1.84M	$ 509.46K	$ 2.08M	$ 723.44K
Cost of Revenue	$ 1.60M	$ 2.07M	$ 1.06M	$ 718.86K	$ 588.88K	$ 293.16K
Gross Profit	$ -1.05M	$ -105.09K	$ 781.28K	$ -209.40K	$ 1.50M	$ 430.28K
Operating Expense	$ 3.83M	$ 482.35K	$ 995.88K	$ 8.88M	$ 6.66M	$ 743.06K
Operating Income	$ -4.84M	$ -587.43K	$ -214.60K	$ -9.09M	$ -5.16M	$ -312.78K
Net Non Operating Interest Income Expense	-	-	-	$ -1.54M	$ -57.02K	-
Other Income Expense	$ -287.00	$ -100.28K	$ -281.00	$ -1.19M	-	-
Pretax Income	$ -4.77M	$ -487.16K	$ -214.88K	$ -11.82M	$ -5.22M	$ -312.78K
Tax Provision	$ 1.42K	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -4.78M	$ -487.16K	$ -214.88K	$ -11.82M	$ -5.22M	$ -312.78K
Basic EPS	$ >-0.01	-	-	$ -0.29	$ -0.13	$ -0.01
Diluted EPS	$ >-0.01	-	-	$ -0.29	$ -0.13	$ -0.01
Basic Average Shares	$ 1.14B	-	-	$ 40.23M	$ 39.73M	$ 20.87M
Diluted Average Shares	$ 1.14B	-	-	$ 40.23M	$ 39.73M	$ 20.87M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	$ -18.63K	-	$ 87.10K	-	-	-
Total Expenses	$ 5.44M	$ 2.55M	$ 2.06M	$ 9.60M	$ 7.25M	$ 1.04M
Net Income From Continuing And Discontinued Operation	$ -4.78M	$ -487.16K	$ -214.88K	$ -11.82M	$ -5.22M	$ -312.78K
Normalized Income	$ -3.13M	-	$ -214.88K	$ -10.63M	$ -5.22M	$ -312.78K
Interest Expense	-	-	-	$ 1.54M	$ 57.02K	-
EBIT	$ -4.88M	$ -487.16K	$ -214.60K	$ -10.28M	$ -5.16M	$ -312.78K
EBITDA	$ -4.03M	$ 1.19M	$ 499.99K	$ -10.22M	$ -5.12M	$ -261.53K

Currency in USD

NuGene International Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing